You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Massachusetts Institute of Technology has ended its journal subscription contract negotiations with Elsevier.
Times Higher Education reports that the University of California and Elsevier may resume negotiations.
Carnegie Mellon University and Elsevier make a "read-and-publish" deal, Inside Higher Ed reports.
A new study finds women are less likely than men to write invited commentaries in medical journals.
More than two dozen University of California researchers are taking a break from their positions on the editorial boards of Elsevier journals, according to ScienceInsider.
Elsevier and a Norwegian consortium come to a "read-and-publish" agreement, according to Nature News.
The University of California has decided to not renew its subscription with the scientific publisher Elsevier.
According to Nature News, researchers in Germany, Hungary, and Sweden have lost access to Elsevier journals as contract talks stall.
Stat News reports that the University of California and publisher Elsevier are fighting over open-access journal payments.
German research institutes are still negotiating with academic publisher Elsevier over cost and open-access polices, Nature News reports.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.